Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;223(6):981-984.
doi: 10.1093/infdis/jiaa789.

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic

Jeffrey R Strich  1   2 , Marcos J Ramos-Benitez  1 , Davide Randazzo  3 , Sydney R Stein  1 , Ashley Babyak  1 , Richard T Davey  4 , Anthony F Suffredini  1 , Richard W Childs  2   5 , Daniel S Chertow  1   2   4
Affiliations

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic

Jeffrey R Strich et al. J Infect Dis. .

Abstract

Neutrophil extracellular traps (NETs) contribute to immunothrombosis and have been associated with mortality in coronavirus disease 2019 (COVID-19). We stimulated donor neutrophils with plasma from patients with COVID-19 and demonstrated that R406 can abrogate the release of NETs. These data provide evidence for how fostamatinib may mitigate neutrophil-associated mechanisms contributing to COVID-19 immunopathogenesis.

Trial registration: ClinicalTrials.gov NCT04579393.

Keywords: COVID-19; fostamatinib; immunothrombosis; neutrophil extracellular traps.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
R406 inhibits NETosis induced by plasma from COVID-19 patients. A, Representative images (10 ×) displaying the kinetics of NETs release visualized using the IncuCyte NETosis assay at 1, 3, and 6 hours comparing stimulation by healthy controls, plasma from a patient with COVID-19, PMA as a positive control, and R406 inhibition (4 μM) of plasma from a patient with COVID-19 and PMA. B, RFU at 6 hours after stimulation were used to compared groups using a Student t test. Horizontal dashed lines represent mean value of each group. Abbreviations: COVID-19, coronavirus disease 2019; NET, neutrophil extracellular trap; PMA, phorbol myristate ester; RFU, relative fluorescent unit.
See this image and copyright information in PMC

References

    1. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med 2020; 383:1813–26. - PMC - PubMed
    1. Recovery Collaborative Group; Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19 - preliminary report [published online ahead of print 17 July 2020]. N Engl J Med doi: 10.1056/NEJMoa2021436. - DOI
    1. Prescott HC, Rice TW. Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic. JAMA 2020; 324:1292–5. - PubMed
    1. Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 2018; 18:134–47. - PubMed
    1. Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 2020; 136:1169–79. - PMC - PubMed

Associated data